1. Home
  2. BEATW vs ECCC Comparison

BEATW vs ECCC Comparison

Compare BEATW & ECCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BEATW
  • ECCC
  • Stock Information
  • Founded
  • BEATW 2015
  • ECCC N/A
  • Country
  • BEATW United States
  • ECCC United States
  • Employees
  • BEATW N/A
  • ECCC N/A
  • Industry
  • BEATW Retail: Computer Software & Peripheral Equipment
  • ECCC Trusts Except Educational Religious and Charitable
  • Sector
  • BEATW Technology
  • ECCC Finance
  • Exchange
  • BEATW Nasdaq
  • ECCC Nasdaq
  • Market Cap
  • BEATW N/A
  • ECCC N/A
  • IPO Year
  • BEATW N/A
  • ECCC N/A
  • Fundamental
  • Price
  • BEATW $0.57
  • ECCC $23.05
  • Analyst Decision
  • BEATW
  • ECCC
  • Analyst Count
  • BEATW 0
  • ECCC 0
  • Target Price
  • BEATW N/A
  • ECCC N/A
  • AVG Volume (30 Days)
  • BEATW 4.7K
  • ECCC N/A
  • Earning Date
  • BEATW 03-14-2025
  • ECCC N/A
  • Dividend Yield
  • BEATW N/A
  • ECCC N/A
  • EPS Growth
  • BEATW N/A
  • ECCC N/A
  • EPS
  • BEATW N/A
  • ECCC N/A
  • Revenue
  • BEATW N/A
  • ECCC N/A
  • Revenue This Year
  • BEATW N/A
  • ECCC N/A
  • Revenue Next Year
  • BEATW N/A
  • ECCC N/A
  • P/E Ratio
  • BEATW N/A
  • ECCC N/A
  • Revenue Growth
  • BEATW N/A
  • ECCC N/A
  • 52 Week Low
  • BEATW $0.50
  • ECCC N/A
  • 52 Week High
  • BEATW $0.62
  • ECCC N/A
  • Technical
  • Relative Strength Index (RSI)
  • BEATW N/A
  • ECCC 52.02
  • Support Level
  • BEATW N/A
  • ECCC $22.95
  • Resistance Level
  • BEATW N/A
  • ECCC $23.05
  • Average True Range (ATR)
  • BEATW 0.00
  • ECCC 0.06
  • MACD
  • BEATW 0.00
  • ECCC 0.01
  • Stochastic Oscillator
  • BEATW 0.00
  • ECCC 93.43

About BEATW Heartbeam Inc.

HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.

About ECCC Eagle Point Credit Company Inc. 6.50% Series C Term Preferred Stock due 2031

Eagle Point Credit Co Inc is an externally managed, non-diversified closed-end management investment company.

Share on Social Networks: